Acclinate utilizes community engagement and predictive insights to enhance diversity in clinical trials by connecting pharmaceutical companies with underrepresented communities of color. This approach addresses the lack of representation in clinical research, helping to meet FDA diversity requirements while reducing recruitment costs and time.
Funding
$13.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BVGFLFounders
Product
Problem
Clinical trials often lack diverse representation, particularly among communities of color, leading to research that may not be broadly applicable. This underrepresentation can result in health disparities and limit the effectiveness of treatments across different populations, while also making it difficult for pharmaceutical companies to meet FDA diversity requirements.
Solution
Acclinate addresses the challenge of underrepresentation in clinical trials by focusing on community engagement and leveraging predictive insights to connect pharmaceutical companies with diverse patient populations. The company's NOWINCLUDED platform fosters trust and provides culturally relevant health information to communities of color, encouraging participation in clinical research. Acclinate also utilizes the e-DICT platform, a predictive analytics tool, to assess community members' willingness to participate in clinical research and identify potential participants. By building affective trust and creating lasting relationships, Acclinate helps pharmaceutical companies increase diversity in their trials, meet regulatory requirements, and improve health equity.
Target Audience
Acclinate's primary customers are pharmaceutical companies and healthcare organizations seeking to increase diversity in clinical trials and improve health equity by engaging with communities of color.
Features
- NOWINCLUDED platform for community engagement and health education tailored to communities of color
- e-DICT platform for predictive analytics to assess community members' willingness to participate in clinical research
- Culturally competent engagement strategies to build trust and foster lasting relationships with underrepresented communities
- Facilitation of access to health information and resources relevant to diverse populations
- Support for pharmaceutical companies in meeting FDA diversity requirements for clinical trials
- Complementary solution designed to diversify existing recruitment strategies